Luma Health vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 38)
Luma Health logo

Luma Health

EmergingHealthcare

Patient Engagement

Patient engagement platform with automated SMS reminders, self-scheduling, and EHR integration for health systems; $130M+ a16z-backed competing with Phreesia for healthcare communication automation.

AI VisibilityBeta
Overall Score
D38
Category Rank
#453 of 596
AI Consensus
84%
Trend
stable
Per Platform
ChatGPT
34
Perplexity
38
Gemini
34

About

Luma Health is a San Francisco-based patient engagement and care orchestration platform that automates patient communication and administrative workflows for healthcare providers — providing appointment reminders, two-way SMS messaging, self-scheduling, waitlist management, referral coordination, and broadcast messaging that integrate directly with major electronic health record (EHR) systems including Epic, Cerner, Athenahealth, and eClinicalWorks. Backed by Andreessen Horowitz and other investors with $130+ million raised, Luma Health serves health systems, hospital groups, and ambulatory practices seeking to reduce no-shows and improve patient access.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
up
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

38
Overall Score
90
#453
Category Rank
#2
84
AI Consensus
83
stable
Trend
up
34
ChatGPT
92
38
Perplexity
93
34
Gemini
89
38
Claude
96
40
Grok
95

Key Details

Category
Patient Engagement
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Luma Health
Patient Engagement

Integrations

Only Moderna
Moderna is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.